Search Results 1551-1560 of 18859 for Insulin

  1. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

    Subjects with controlled Type 1 diabetes mellitus who are on an insulin regimen are eligible for the study - Subjects with eczema, psoriasis, lichen simplex ...

  2. Diazoxide choline (oral route) - Side effects & dosage - Mayo Clinic

    May make these conditions worse. Hyperinsulinemic hypoglycemia (low blood sugar caused by excess insulin) or; Kidney disease or; Liver disease—Use is not ...

  3. Expert Alert: Getting back into the swing of golf - Mayo Clinic News Network

    Rhoda Madson, Mayo Clinic Public Affairs, newsbureau@mayo.edu · Researchers Question if Inflammation or Fat Cell Size Affects Insulin Resistance · Experience ...

  4. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

    Note: replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not ...

  5. Fatigue - Mayo Clinic

    Insomnia: How do I stay asleep? Insulin and weight gain · Is there a special diet for Crohn's disease? Jack Long — Live LONG - Beat STRONG to find a cure · Jet ...

  6. A Study To Compare Standard Therapy To Treat Hodgkin Lymphoma To The Use Of Two Drugs, Brentuximab Vedotin And Nivolumab - Mayo Clinic

    Note: Replacement therapy such as thyroxine, insulin, or physiologic corticosteroid for adrenal or pituitary insufficiency is not considered a form of systemic ...

  7. Mayo Clinic Q&A podcast: COVID-19 update

    Researchers Question if Inflammation or Fat Cell Size Affects Insulin Resistance. Related Articles. Mayo Clinic Minute: COVID-19 at-home tests and expiration ...

  8. Publications - Khalid Benkhadra, M.D. - Mayo Clinic

    2017 Jan; 23(1):17-31. Epub 2016 Sep 15. View PubMed; Benkhadra K, Alahdab F, Tamhane SU, McCoy RG, Prokop LJ, Murad MH. Continuous subcutaneous insulin ...

  9. Publications - Frank V. Brozovich, M.D., Ph.D. - Mayo Clinic

    Graf RJ, Halter JB, Pfeifer MA, Halar E, Brozovich F, Porte D Jr. Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects ...

  10. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    Patients with controlled Type 1 diabetes mellitus on a stable insulin regimen may be eligible for this study. Patients with eczema, psoriasis, lichen ...